Clindamycin Hydrochloride Powder is a potent antibiotic commonly employed in microbiology for its efficacy against various bacterial infections. This versatile compound inhibits bacterial growth by targeting the protein synthesis process in bacteria.
In microbiological laboratories, Clindamycin Hydrochloride Powder is crucial for creating selective culture media that suppress bacterial growth. Moreover, microbiologists rely on its broad-spectrum activity to study and identify different bacterial strains, providing valuable insights into their characteristics.
Additionally, Clindamycin Hydrochloride Powder is vital for antimicrobial susceptibility testing. This method is essential for determining the most effective antibiotic treatment. Microbiologists use Clindamycin Hydrochloride Powder to assess bacterial sensitivity to different antibiotics, aiding in treatment selection.
Furthermore, researchers often use Clindamycin Hydrochloride Powder to investigate bacterial resistance mechanisms. By exposing bacteria to this antibiotic, scientists can study the development of resistance and devise strategies to combat it effectively.
Overall, Clindamycin Hydrochloride Powder plays a pivotal role in microbiology labs. Its ability to inhibit bacterial growth, usefulness in susceptibility testing, and role in studying resistance mechanisms make it an indispensable tool for microbiologists and researchers.
Cat. Number | AS-2009 |
CAS Number | 21462-39-5 |
Additional CAS | 18323-44-9 |
Additional CAS | 58207-19-5 |
MDL Number | MFCD07793327 |
Pubchem | 310270392 |
Molecular Weight | 461.44 g/mol |
Molecular Formula | C18H34Cl2N2O5S |
Storage Temperature | 4°C |
Form and Color | Powder to crystalline powder, white to off-white |
Assay | ≥ 800 µg/mg |
pH (10% in water) | 3 – 5.5 |
Water | 3 – 6% |
1H-NMR Spectrum | Corresponds to assigned structure. |
Synonym | Cleocin; (7S)-7-Chloro-7-deoxylincomycin hydrochloride |